The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
Hepatitis C virus (HCV) currently infects approximately 250,000 individuals in Canada and causes more years of life lost than any other infectious disease in the country. In August 2011, new therapies were approved by Health Canada that have achieved higher response rates among those treated, but ar...
Published in: | Canadian Journal of Gastroenterology and Hepatology |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Format: | Other/Unknown Material |
Language: | English |
Published: |
Canadian Journal of Gastroenterology and Hepatology
2014
|
Subjects: | |
Online Access: | https://doi.org/10.1155/2014/704919 |
id |
fthindawi:oai:hindawi.com:10.1155/2014/704919 |
---|---|
record_format |
openpolar |
spelling |
fthindawi:oai:hindawi.com:10.1155/2014/704919 2023-05-15T16:16:44+02:00 The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era Sonya A MacParland Marc Bilodeau Jason Grebely Julie Bruneau Curtis Cooper Marina Klein Selena M Sagan Norma Choucha Louise Balfour Frank Bialystok Mel Krajden Jennifer Raven Eve Roberts Rodney Russell Michael Houghton D Lorne Tyrrell Jordan J Feld 2014 https://doi.org/10.1155/2014/704919 en eng Canadian Journal of Gastroenterology and Hepatology https://doi.org/10.1155/2014/704919 Copyright © 2014 Canadian Association for the Study of the Liver. Commentary 2014 fthindawi https://doi.org/10.1155/2014/704919 2019-05-26T05:16:43Z Hepatitis C virus (HCV) currently infects approximately 250,000 individuals in Canada and causes more years of life lost than any other infectious disease in the country. In August 2011, new therapies were approved by Health Canada that have achieved higher response rates among those treated, but are poorly tolerated. By 2014/2015, short-course, well-tolerated treatments with cure rates >95% will be available. However, treatment uptake is poor due to structural, financial, geographical, cultural and social barriers. As such, ‘Barriers to access to HCV care in Canada’ is a crucial topic that must be addressed to decrease HCV disease burden and potentially eliminate HCV in Canada. Understanding how to better care for HCV-infected individuals requires integration across multiple disciplines including researchers, clinical services and policy makers to address the major populations affected by HCV including people who inject drugs, baby boomers, immigrants and Aboriginal and/or First Nations people. In 2012, the National CIHR Research Training Program in Hepatitis C organized the 1st Canadian Symposium on Hepatitis C Virus (CSHCV) in Montreal, Quebec. The 2nd CSHCV was held in 2013 in Victoria, British Columbia. Both symposia were highly successful, attracting leading international faculty with excellent attendance leading to dialogue and knowledge translation among attendees of diverse backgrounds. The current article summarizes the 3rd CSHCV, held February 2014, in Toronto, Ontario. Other/Unknown Material First Nations Hindawi Publishing Corporation British Columbia ENVELOPE(-125.003,-125.003,54.000,54.000) Canada Canadian Journal of Gastroenterology and Hepatology 28 9 481 487 |
institution |
Open Polar |
collection |
Hindawi Publishing Corporation |
op_collection_id |
fthindawi |
language |
English |
description |
Hepatitis C virus (HCV) currently infects approximately 250,000 individuals in Canada and causes more years of life lost than any other infectious disease in the country. In August 2011, new therapies were approved by Health Canada that have achieved higher response rates among those treated, but are poorly tolerated. By 2014/2015, short-course, well-tolerated treatments with cure rates >95% will be available. However, treatment uptake is poor due to structural, financial, geographical, cultural and social barriers. As such, ‘Barriers to access to HCV care in Canada’ is a crucial topic that must be addressed to decrease HCV disease burden and potentially eliminate HCV in Canada. Understanding how to better care for HCV-infected individuals requires integration across multiple disciplines including researchers, clinical services and policy makers to address the major populations affected by HCV including people who inject drugs, baby boomers, immigrants and Aboriginal and/or First Nations people. In 2012, the National CIHR Research Training Program in Hepatitis C organized the 1st Canadian Symposium on Hepatitis C Virus (CSHCV) in Montreal, Quebec. The 2nd CSHCV was held in 2013 in Victoria, British Columbia. Both symposia were highly successful, attracting leading international faculty with excellent attendance leading to dialogue and knowledge translation among attendees of diverse backgrounds. The current article summarizes the 3rd CSHCV, held February 2014, in Toronto, Ontario. |
format |
Other/Unknown Material |
author |
Sonya A MacParland Marc Bilodeau Jason Grebely Julie Bruneau Curtis Cooper Marina Klein Selena M Sagan Norma Choucha Louise Balfour Frank Bialystok Mel Krajden Jennifer Raven Eve Roberts Rodney Russell Michael Houghton D Lorne Tyrrell Jordan J Feld |
spellingShingle |
Sonya A MacParland Marc Bilodeau Jason Grebely Julie Bruneau Curtis Cooper Marina Klein Selena M Sagan Norma Choucha Louise Balfour Frank Bialystok Mel Krajden Jennifer Raven Eve Roberts Rodney Russell Michael Houghton D Lorne Tyrrell Jordan J Feld The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era |
author_facet |
Sonya A MacParland Marc Bilodeau Jason Grebely Julie Bruneau Curtis Cooper Marina Klein Selena M Sagan Norma Choucha Louise Balfour Frank Bialystok Mel Krajden Jennifer Raven Eve Roberts Rodney Russell Michael Houghton D Lorne Tyrrell Jordan J Feld |
author_sort |
Sonya A MacParland |
title |
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era |
title_short |
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era |
title_full |
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era |
title_fullStr |
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era |
title_full_unstemmed |
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era |
title_sort |
3rd canadian symposium on hepatitis c virus: expanding care in the interferon-free era |
publisher |
Canadian Journal of Gastroenterology and Hepatology |
publishDate |
2014 |
url |
https://doi.org/10.1155/2014/704919 |
long_lat |
ENVELOPE(-125.003,-125.003,54.000,54.000) |
geographic |
British Columbia Canada |
geographic_facet |
British Columbia Canada |
genre |
First Nations |
genre_facet |
First Nations |
op_relation |
https://doi.org/10.1155/2014/704919 |
op_rights |
Copyright © 2014 Canadian Association for the Study of the Liver. |
op_doi |
https://doi.org/10.1155/2014/704919 |
container_title |
Canadian Journal of Gastroenterology and Hepatology |
container_volume |
28 |
container_issue |
9 |
container_start_page |
481 |
op_container_end_page |
487 |
_version_ |
1766002584672272384 |